Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EKC-Cide
- Development stage
- Preclinical
- Lead developer
- NanoViricides
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
EKC-Cide is a nanoviricide drug candidate being developed by NanoViricides, Inc. for the treatment of epidemic kerato-conjunctivitis (EKC), a severe and highly contagious ocular infection caused by human adenoviruses. The drug is based on a proprietary nanomedicine platform that utilizes polymeric micelles (nanoviricides) designed to mimic the host cell surface receptors that viruses use for attachment. By presenting a high density of these decoy ligands, EKC-Cide binds to and neutralizes viral particles, effectively preventing them from infecting ocular tissues. It has shown efficacy in confirmatory animal models and aims to address a significant unmet medical need, as there are currently no approved antiviral treatments for EKC.
- Other names
- EKC-Cide
02
Targets
Adenovirus capsid attachment proteins
Beyond the preview
Go deeper on EKC-Cide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EKC-Cide.